Evaluation of a Mobile Menopause Application

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorEndo Health GmbH

About this trial

This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.

Eligibility criteria

Qualifiers

Legal capacity

Ability to provide informed consent

Residency in Germany

Female gender

Disqualifiers

Pregnancy or breastfeeding during the study period

Current hormonal replacement therapy (HRT), initiation of HRT within eight weeks prior to study start and/or planned start of HRT during the study period

Changes in treatment with psychotropic medication within eight weeks prior to study start and/or planned during the study period

Start of psychotherapy within eight weeks prior to study start and/or planned during the study period

Trial design

Treatments tested in this trial

  • Menopause App

Treatment groups

426 Participants
are divided into 2 treatment groups

Sponsors and collaborators